FULVESTRANT

FULVESTRANT was reported 33512 times

FULVESTRANT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PIK3CA-ACTIVATED MUTATION 166 0.5000
1 HORMONE RECEPTOR POSITIVE HER2 NEGATIVE BREAST CANCER 132 0.3976
2 CARBOHYDRATE ANTIGEN 15-3 INCREASED 253 0.3325
3 ELLIPTOCYTOSIS 26 0.2889
4 CARBOHYDRATE ANTIGEN 27.29 INCREASED 38 0.2533
5 INFUSION SITE COLDNESS 24 0.2400
6 PSEUDOCIRRHOSIS 79 0.2380
7 METASTASES TO THORAX 47 0.1858
8 METASTASES TO EYE 39 0.1781
9 PLEURAL NEOPLASM 29 0.1758
10 METASTASES TO SPINAL CORD 33 0.1701
11 METASTASES TO PLEURA 173 0.1649
12 TUMOUR MARKER ABNORMAL 53 0.1601
13 BREAST CANCER METASTATIC 1696 0.1578
14 METASTASES TO SKIN 162 0.1568
15 TUMOUR MARKER INCREASED 675 0.1405
16 METASTASES TO BONE 2179 0.1326
17 METASTASES TO CHEST WALL 45 0.1297
18 METASTASES TO BREAST 43 0.1295
19 GAMMA-GLUTAMYLTRANSFERASE DECREASED 24 0.1250
20 TUMOUR MARKER DECREASED 22 0.1229
21 NAIL BED INFLAMMATION 39 0.1223
22 ADNEXA UTERI MASS 35 0.1211
23 MUSCULOSKELETAL TOXICITY 21 0.1129
24 METASTASES TO LIVER 1779 0.1011
25 CHEST WALL MASS 26 0.1000
26 HORMONE RECEPTOR POSITIVE BREAST CANCER 27 0.0993
27 BREAST CANCER RECURRENT 312 0.0987
28 METASTASES TO PELVIS 62 0.0981
29 METASTASES TO THE MEDIASTINUM 40 0.0971
30 INTESTINAL METASTASIS 35 0.0964
31 METASTASES TO SPINE 320 0.0951
32 METASTASES TO OVARY 29 0.0909
33 OESTRADIOL INCREASED 25 0.0831
34 BONE MARROW INFILTRATION 32 0.0827
35 INVASIVE LOBULAR BREAST CARCINOMA 42 0.0819
36 NASAL MUCOSAL DISORDER 47 0.0806
37 POIKILOCYTOSIS 21 0.0758
38 INVASIVE BREAST CARCINOMA 30 0.0726
39 BONE LESION 262 0.0726
40 METASTASES TO BONE MARROW 36 0.0720
41 METASTASES TO LYMPH NODES 468 0.0693
42 CARCINOEMBRYONIC ANTIGEN INCREASED 134 0.0691
43 METASTASES TO LUNG 790 0.0683
44 BONE CANCER METASTATIC 33 0.0624
45 SCAN ABNORMAL 23 0.0623
46 NEOPLASM PROGRESSION 2130 0.0612
47 BLOOD ALBUMIN ABNORMAL 31 0.0595
48 METASTASES TO STOMACH 23 0.0587
49 OSTEOSCLEROSIS 92 0.0584
50 METASTASES TO PERITONEUM 147 0.0581
51 ANISOCYTOSIS 38 0.0578
52 OSTEOLYSIS 112 0.0547
53 HYPERMETABOLISM 29 0.0547
54 PRIMARY SEQUESTRUM 48 0.0530
55 MALIGNANT PLEURAL EFFUSION 88 0.0521
56 POSITRON EMISSION TOMOGRAM ABNORMAL 36 0.0515
57 MENINGOENCEPHALITIS HERPETIC 23 0.0513
58 PLEURAL THICKENING 34 0.0497
59 METASTASIS 355 0.0497
60 STREPTOCOCCAL SEPSIS 58 0.0489
61 INVASIVE DUCTAL BREAST CARCINOMA 131 0.0481
62 METASTASES TO ADRENALS 41 0.0444
63 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 55 0.0441
64 DECREASED IMMUNE RESPONSIVENESS 426 0.0434
65 MEAN CELL HAEMOGLOBIN INCREASED 71 0.0428
66 VERTEBRAL FORAMINAL STENOSIS 35 0.0425
67 MALIGNANT NEOPLASM PROGRESSION 4341 0.0423
68 PLEURAL DISORDER 26 0.0414
69 HILAR LYMPHADENOPATHY 36 0.0409
70 HEPATIC LESION 177 0.0409
71 BLOOD BILIRUBIN ABNORMAL 50 0.0390
72 ABDOMINAL LYMPHADENOPATHY 33 0.0380
73 CANCER PAIN 97 0.0379
74 LYMPHANGIOSIS CARCINOMATOSA 39 0.0374
75 MALIGNANT ASCITES 27 0.0352
76 INTERVERTEBRAL DISC SPACE NARROWING 27 0.0335
77 EXCESSIVE GRANULATION TISSUE 27 0.0335
78 LYMPHADENOPATHY MEDIASTINAL 64 0.0334
79 BASOPHIL COUNT INCREASED 25 0.0330
80 MEAN CELL VOLUME INCREASED 83 0.0323
81 PLEURAL FIBROSIS 31 0.0304
82 PSEUDOMONAL SEPSIS 53 0.0302
83 METASTASES TO CENTRAL NERVOUS SYSTEM 387 0.0300
84 EXPOSED BONE IN JAW 65 0.0300
85 POST-TRAUMATIC NECK SYNDROME 24 0.0297
86 OSTEONECROSIS OF JAW 692 0.0279
87 BLOOD ALKALINE PHOSPHATASE ABNORMAL 25 0.0278
88 SECOND PRIMARY MALIGNANCY 221 0.0265
89 INJECTION SITE NECROSIS 54 0.0265
90 HEPATIC MASS 51 0.0265
91 DILATED CARDIOMYOPATHY 26 0.0257
92 LYMPHOEDEMA 176 0.0254
93 METASTASES TO MENINGES 57 0.0250
94 MACROCYTOSIS 29 0.0250
95 MONOCYTE COUNT DECREASED 30 0.0246
96 OVARIAN DISORDER 23 0.0245
97 FRACTURED SACRUM 30 0.0241
98 NEUTROPHIL COUNT ABNORMAL 67 0.0237
99 ACQUIRED GENE MUTATION 31 0.0236
100 BLOOD CALCIUM ABNORMAL 39 0.0234
101 GENE MUTATION 46 0.0232
102 HEPATIC CYST 78 0.0229
103 RED CELL DISTRIBUTION WIDTH INCREASED 95 0.0228
104 BLOOD CREATININE ABNORMAL 79 0.0228
105 BILE DUCT STENOSIS 27 0.0225
106 BONE NEOPLASM 24 0.0223
107 TUMOUR PAIN 29 0.0220
108 VASCULAR CALCIFICATION 23 0.0216
109 PATHOLOGICAL FRACTURE 108 0.0213
110 ACTINOMYCOSIS 20 0.0209
111 ALANINE AMINOTRANSFERASE ABNORMAL 44 0.0208
112 BODY MASS INDEX INCREASED 28 0.0207
113 NEUTROPHIL COUNT DECREASED 845 0.0207
114 WHITE BLOOD CELL COUNT DECREASED 2247 0.0207
115 ABSCESS JAW 21 0.0202
116 HYPERGLYCAEMIA 731 0.0200
117 NEOPLASM RECURRENCE 67 0.0197
118 VULVOVAGINAL DRYNESS 62 0.0192
119 ASPARTATE AMINOTRANSFERASE ABNORMAL 29 0.0190
120 METASTATIC NEOPLASM 82 0.0190
121 RED BLOOD CELL COUNT DECREASED 542 0.0189
122 SKIN TOXICITY 106 0.0187
123 NEUTROPENIA 2542 0.0187
124 WHITE BLOOD CELL COUNT ABNORMAL 119 0.0186
125 SUPERINFECTION 27 0.0180
126 PERIODONTAL DISEASE 25 0.0178
127 BREAST CANCER STAGE IV 50 0.0176
128 AORTIC ARTERIOSCLEROSIS 45 0.0175
129 FULL BLOOD COUNT ABNORMAL 181 0.0171
130 DISCOURAGEMENT 40 0.0171
131 MEAN CELL HAEMOGLOBIN DECREASED 31 0.0169
132 FULL BLOOD COUNT DECREASED 339 0.0168
133 PERIODONTITIS 36 0.0166
134 ADENOCARCINOMA 37 0.0165
135 MUCOSAL DRYNESS 33 0.0164
136 BLOOD CREATININE DECREASED 51 0.0163
137 PORTAL HYPERTENSION 50 0.0162
138 BONE CANCER 70 0.0161
139 WHITE BLOOD CELL DISORDER 43 0.0161
140 ONYCHOCLASIS 110 0.0160
141 PULMONARY MASS 236 0.0158
142 RED BLOOD CELL COUNT ABNORMAL 23 0.0156
143 VOCAL CORD PARALYSIS 28 0.0156
144 RADICULOPATHY 41 0.0155
145 INFUSION SITE INDURATION 23 0.0155
146 POLYNEUROPATHY 179 0.0149
147 LEUKOPENIA 744 0.0149
148 SPINAL PAIN 173 0.0147
149 PARONYCHIA 64 0.0145
150 BONE DISORDER 262 0.0144
151 ASCITES 422 0.0143
152 HAEMATOTOXICITY 132 0.0139
153 SPONDYLOLISTHESIS 24 0.0138
154 NAIL DISORDER 121 0.0138
155 VITILIGO 32 0.0136
156 BONE MARROW DISORDER 39 0.0129
157 HEPATIC NEOPLASM 42 0.0129
158 PROTEIN TOTAL INCREASED 34 0.0128
159 URINE ODOUR ABNORMAL 75 0.0127
160 RECURRENT CANCER 52 0.0127
161 LOOSE TOOTH 41 0.0127
162 PLEURAL EFFUSION 770 0.0126
163 JAW DISORDER 69 0.0126
164 HAEMOGLOBIN ABNORMAL 81 0.0126
165 KYPHOSIS 22 0.0124
166 NEOPLASM 141 0.0123
167 BREAST DISORDER 25 0.0122
168 VARICOSE VEIN 62 0.0120
169 CONCOMITANT DISEASE AGGRAVATED 74 0.0120
170 BONE PAIN 698 0.0119
171 BREAST MASS 80 0.0119
172 OSTEITIS 30 0.0119
173 MUSCULOSKELETAL CHEST PAIN 184 0.0119
174 SPINAL CORD COMPRESSION 46 0.0118
175 VASCULAR DEVICE INFECTION 53 0.0117
176 PORTAL VEIN THROMBOSIS 37 0.0114
177 MUCOSAL INFLAMMATION 299 0.0114
178 VEIN DISORDER 57 0.0114
179 DISEASE PROGRESSION 1346 0.0114
180 GINGIVAL SWELLING 50 0.0113
181 ERYTHEMA MULTIFORME 105 0.0112
182 HAEMANGIOMA 26 0.0112
183 BLOOD COUNT ABNORMAL 170 0.0112
184 MYELOSUPPRESSION 396 0.0110
185 HYDRONEPHROSIS 82 0.0109
186 STOMATITIS 661 0.0109
187 SPINAL OSTEOARTHRITIS 95 0.0108
188 GINGIVITIS 58 0.0107
189 PLATELET COUNT ABNORMAL 65 0.0107
190 ERYSIPELAS 54 0.0107
191 APHTHOUS ULCER 81 0.0104
192 ORAL PAIN 232 0.0104
193 BREAST CANCER 962 0.0103
194 VASODILATATION 26 0.0103
195 CACHEXIA 53 0.0103
196 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 238 0.0102
197 JAW FRACTURE 22 0.0102
198 BREAST SWELLING 27 0.0100
199 LYMPHADENITIS 24 0.0099
200 HAEMATOCRIT DECREASED 192 0.0097
201 PERIARTHRITIS 22 0.0097
202 DIVERTICULUM INTESTINAL 42 0.0096
203 PNEUMONITIS 261 0.0096
204 LYMPHADENOPATHY 336 0.0095
205 TONGUE BLISTERING 21 0.0094
206 BREAST PAIN 100 0.0094
207 GASTROINTESTINAL TOXICITY 45 0.0094
208 ATELECTASIS 90 0.0093
209 GINGIVAL PAIN 74 0.0093
210 BODY HEIGHT DECREASED 99 0.0092
211 HEPATOTOXICITY 205 0.0092
212 BONE MARROW FAILURE 186 0.0091
213 PIGMENTATION DISORDER 56 0.0091
214 HYPERTRANSAMINASAEMIA 63 0.0090
215 PURULENT DISCHARGE 38 0.0089
216 HEPATIC FAILURE 268 0.0089
217 VOLVULUS 21 0.0089
218 MASTICATION DISORDER 27 0.0088
219 HEPATOMEGALY 86 0.0087
220 DIASTOLIC DYSFUNCTION 27 0.0087
221 ORAL DISORDER 64 0.0087
222 PANNICULITIS 21 0.0087
223 TOOTHACHE 157 0.0087
224 CYTOPENIA 106 0.0086
225 NASAL DRYNESS 54 0.0086
226 GOITRE 35 0.0085
227 MONOCYTE COUNT INCREASED 31 0.0085
228 OESOPHAGEAL STENOSIS 24 0.0084
229 SKIN MASS 56 0.0084
230 GLOMERULAR FILTRATION RATE DECREASED 103 0.0084
231 LUNG OPACITY 22 0.0083
232 OSTEOMYELITIS 151 0.0083
233 PLATELET DISORDER 21 0.0083
234 TRANSAMINASES INCREASED 184 0.0083
235 DENTAL CARIES 91 0.0082
236 PLATELET COUNT DECREASED 868 0.0081
237 CEREBRAL THROMBOSIS 23 0.0081
238 PAIN IN JAW 230 0.0081
239 PAROSMIA 61 0.0081
240 BLOOD ALKALINE PHOSPHATASE INCREASED 200 0.0080
241 OVARIAN CANCER 74 0.0080
242 THYROID NEOPLASM 22 0.0080
243 TRICUSPID VALVE INCOMPETENCE 63 0.0079
244 CARBOHYDRATE ANTIGEN 125 INCREASED 27 0.0079
245 GRANULOCYTOPENIA 45 0.0079
246 LIVER FUNCTION TEST INCREASED 169 0.0079
247 NECK MASS 22 0.0078
248 THORACIC VERTEBRAL FRACTURE 23 0.0078
249 BLOOD TEST ABNORMAL 109 0.0078
250 TASTE DISORDER 157 0.0077
251 THROMBOCYTOPENIA 855 0.0076
252 EJECTION FRACTION DECREASED 116 0.0075
253 MOUTH SWELLING 43 0.0074
254 GAMMA-GLUTAMYLTRANSFERASE INCREASED 165 0.0074
255 HAEMOGLOBIN DECREASED 764 0.0074
256 PROTEIN TOTAL DECREASED 28 0.0074
257 RENAL CYST 59 0.0074
258 ACUTE LYMPHOCYTIC LEUKAEMIA 21 0.0074
259 FACET JOINT SYNDROME 24 0.0074
260 EATING DISORDER 156 0.0073
261 TOOTH EXTRACTION 91 0.0073
262 NODULE 95 0.0073
263 TOOTH FRACTURE 80 0.0072
264 BLOOD CALCIUM DECREASED 81 0.0072
265 RHINITIS ALLERGIC 32 0.0072
266 HOT FLUSH 541 0.0072
267 ORAL INFECTION 28 0.0072
268 RECTAL CANCER 22 0.0072
269 LUNG INFILTRATION 63 0.0071
270 THROMBOPHLEBITIS 25 0.0071
271 ALOPECIA 1400 0.0071
272 ASPARTATE AMINOTRANSFERASE INCREASED 378 0.0071
273 COMPRESSION FRACTURE 38 0.0071
274 SCIATICA 113 0.0071
275 BRAIN OEDEMA 89 0.0070
276 GLOSSITIS 25 0.0070
277 HEPATIC STEATOSIS 131 0.0070
278 GINGIVAL DISORDER 27 0.0070
279 HEPATIC ENZYME ABNORMAL 35 0.0070
280 SPINAL COMPRESSION FRACTURE 58 0.0070
281 BLOOD BILIRUBIN INCREASED 189 0.0070
282 INFUSION SITE HAEMORRHAGE 23 0.0070
283 ANAEMIA 1333 0.0070
284 THERAPY PARTIAL RESPONDER 109 0.0070
285 SCOLIOSIS 43 0.0069
286 MASS 97 0.0069
287 ODYNOPHAGIA 41 0.0069
288 CLAVICLE FRACTURE 26 0.0068
289 DYSPNOEA EXERTIONAL 253 0.0067
290 FEEDING DISORDER 136 0.0067
291 NEUROPATHY PERIPHERAL 636 0.0067
292 SKIN ATROPHY 38 0.0066
293 OSTEONECROSIS 216 0.0066
294 IMMUNODEFICIENCY 98 0.0066
295 SPINAL COLUMN STENOSIS 31 0.0066
296 HYPERCALCAEMIA 81 0.0066
297 HEPATIC PAIN 28 0.0066
298 SYNOVIAL CYST 30 0.0065
299 PHLEBITIS 33 0.0064
300 INTERSTITIAL LUNG DISEASE 312 0.0064
301 LYMPHOCYTE COUNT INCREASED 21 0.0064
302 DECREASED APPETITE 1484 0.0064
303 TOOTH ABSCESS 65 0.0064
304 OSTEOPENIA 96 0.0063
305 FLANK PAIN 59 0.0063
306 FOOD INTOLERANCE 23 0.0063
307 DECREASED INTEREST 37 0.0063
308 GENERAL PHYSICAL HEALTH DETERIORATION 724 0.0063
309 THYROID MASS 24 0.0062
310 LACRIMATION INCREASED 188 0.0062
311 BLOOD CREATININE INCREASED 406 0.0062
312 TONGUE ULCERATION 21 0.0062
313 ONYCHOMADESIS 26 0.0062
314 HIATUS HERNIA 80 0.0062
315 INTERVERTEBRAL DISC DEGENERATION 57 0.0062
316 HYPERPYREXIA 26 0.0061
317 TRIGGER FINGER 25 0.0061
318 NAIL DISCOLOURATION 24 0.0061
319 CANDIDA INFECTION 103 0.0061
320 FEMORAL NECK FRACTURE 31 0.0060
321 OESOPHAGITIS 66 0.0060
322 MADAROSIS 70 0.0060
323 IMMUNOSUPPRESSION 53 0.0060
324 RHINITIS 48 0.0059
325 TOOTH DISORDER 132 0.0059
326 BLOOD CALCIUM INCREASED 52 0.0059
327 MITRAL VALVE INCOMPETENCE 67 0.0059
328 HYPOALBUMINAEMIA 46 0.0059
329 HEPATIC CIRRHOSIS 110 0.0058
330 CARDIOMEGALY 72 0.0058
331 GASTRITIS 154 0.0058
332 SKIN ODOUR ABNORMAL 23 0.0058
333 IRON DEFICIENCY 26 0.0058
334 YELLOW SKIN 27 0.0058
335 HORMONE LEVEL ABNORMAL 28 0.0057
336 LIVER DISORDER 254 0.0057
337 SPINAL DISORDER 54 0.0057
338 BUNDLE BRANCH BLOCK LEFT 24 0.0057
339 JAUNDICE 152 0.0056
340 ALANINE AMINOTRANSFERASE INCREASED 344 0.0056
341 APPETITE DISORDER 37 0.0056
342 LYMPHOCYTE COUNT DECREASED 98 0.0055
343 BLOOD URIC ACID INCREASED 32 0.0055
344 OCULAR ICTERUS 24 0.0055
345 TRIGEMINAL NEURALGIA 22 0.0055
346 FATIGUE 4249 0.0055
347 ARTERIOSCLEROSIS CORONARY ARTERY 36 0.0054
348 OROPHARYNGEAL DISCOMFORT 49 0.0054
349 IMPAIRED HEALING 178 0.0054
350 SKIN FISSURES 105 0.0054
351 LABORATORY TEST ABNORMAL 158 0.0053
352 PERIPHERAL SENSORY NEUROPATHY 31 0.0053
353 CEREBRAL ATROPHY 21 0.0053
354 CEREBRAL ISCHAEMIA 27 0.0052
355 TOOTH INFECTION 69 0.0052
356 PULMONARY TOXICITY 37 0.0052
357 VITAMIN D DEFICIENCY 51 0.0052
358 ELECTROCARDIOGRAM QT PROLONGED 188 0.0052
359 PANCYTOPENIA 292 0.0052
360 OVERWEIGHT 28 0.0052
361 NECROSIS 29 0.0052
362 FEELING COLD 145 0.0052
363 RIB FRACTURE 107 0.0052
364 STRESS CARDIOMYOPATHY 30 0.0052
365 INTERVERTEBRAL DISC DISORDER 22 0.0051
366 PERFORMANCE STATUS DECREASED 24 0.0051
367 PERIPHERAL VENOUS DISEASE 21 0.0051
368 DRUG INTOLERANCE 496 0.0051
369 MOUTH ULCERATION 108 0.0051
370 DRUG RESISTANCE 131 0.0051
371 HEPATIC FUNCTION ABNORMAL 190 0.0051
372 JOINT EFFUSION 35 0.0051
373 HAEMORRHOIDS 99 0.0051
374 MUSCULOSKELETAL DISCOMFORT 87 0.0050
375 CARDIOTOXICITY 45 0.0050
376 NEUTROPHIL COUNT INCREASED 51 0.0050
377 PHYSICAL DISABILITY 22 0.0050
378 TONGUE DISCOMFORT 21 0.0049
379 EXOSTOSIS 45 0.0049
380 BLOOD LACTATE DEHYDROGENASE INCREASED 78 0.0049
381 HAIR TEXTURE ABNORMAL 65 0.0049
382 ASTHENIA 1812 0.0048
383 EMBOLISM 40 0.0048
384 BACK PAIN 1117 0.0048
385 VITAMIN D DECREASED 41 0.0048
386 BLOOD ALBUMIN DECREASED 38 0.0048
387 GROIN PAIN 42 0.0048
388 HYPERLIPIDAEMIA 57 0.0048
389 HAIR GROWTH ABNORMAL 33 0.0048
390 PERICARDIAL EFFUSION 110 0.0048
391 BLOOD UREA INCREASED 79 0.0047
392 SKIN LESION 129 0.0047
393 TENDERNESS 49 0.0047
394 ENDOCARDITIS 24 0.0047
395 PRODUCT SUPPLY ISSUE 33 0.0046
396 AGEUSIA 115 0.0046
397 SENSORY LOSS 37 0.0046
398 FEELING OF DESPAIR 21 0.0045
399 LEFT VENTRICULAR DYSFUNCTION 30 0.0045
400 EPISTAXIS 335 0.0045
401 PLATELET COUNT INCREASED 58 0.0044
402 MUSCULOSKELETAL PAIN 231 0.0044
403 NERVE INJURY 49 0.0044
404 HYPERTENSIVE CRISIS 49 0.0044
405 BLOOD GLUCOSE ABNORMAL 81 0.0044
406 ABDOMINAL HERNIA 20 0.0044
407 INCONTINENCE 46 0.0043
408 MUSCLE ATROPHY 55 0.0043
409 SENSITIVE SKIN 32 0.0043
410 DIABETIC KETOACIDOSIS 104 0.0043
411 CONSTIPATION 939 0.0043
412 METABOLIC DISORDER 25 0.0043
413 HAEMORRHOIDAL HAEMORRHAGE 21 0.0043
414 SENSORY DISTURBANCE 69 0.0043
415 DECUBITUS ULCER 35 0.0043
416 CENTRAL NERVOUS SYSTEM LESION 59 0.0043
417 GINGIVAL BLEEDING 58 0.0042
418 PELVIC FRACTURE 33 0.0042
419 LIVER INJURY 104 0.0042
420 MOVEMENT DISORDER 136 0.0042
421 LIMB DISCOMFORT 131 0.0042
422 ECCHYMOSIS 29 0.0042
423 PULMONARY OEDEMA 189 0.0042
424 C-REACTIVE PROTEIN INCREASED 153 0.0042
425 FAECALOMA 23 0.0042
426 WOUND 117 0.0042
427 DIARRHOEA 2684 0.0042
428 ENTEROCOLITIS 24 0.0042
429 BRONCHIECTASIS 28 0.0042
430 COUGH 1163 0.0041
431 ARTERIOSCLEROSIS 39 0.0041
432 HEPATITIS 106 0.0041
433 SKIN DISORDER 138 0.0041
434 GENERAL PHYSICAL CONDITION ABNORMAL 28 0.0041
435 FAECES SOFT 30 0.0041
436 HYPOCALCAEMIA 78 0.0041
437 FISTULA 46 0.0041
438 FRACTURE 77 0.0041
439 RETINAL DETACHMENT 37 0.0040
440 PULMONARY EMBOLISM 382 0.0040
441 TONGUE DISORDER 29 0.0040
442 HAIR DISORDER 33 0.0040
443 NEURALGIA 97 0.0040
444 INTERVERTEBRAL DISC PROTRUSION 87 0.0040
445 HYPOKALAEMIA 182 0.0039
446 DRY THROAT 40 0.0039
447 MALNUTRITION 44 0.0039
448 FOOD POISONING 21 0.0039
449 HAEMATOMA 101 0.0039
450 NAUSEA 3085 0.0039
451 WEIGHT DECREASED 1081 0.0039
452 POOR VENOUS ACCESS 40 0.0039
453 DERMATITIS 81 0.0039
454 BODY TEMPERATURE DECREASED 38 0.0039
455 LIP DRY 35 0.0038
456 HYPERCHOLESTEROLAEMIA 37 0.0038
457 PRODUCT DOSE OMISSION IN ERROR 108 0.0038
458 SCAR 65 0.0038
459 CELLULITIS 191 0.0038
460 CORONAVIRUS INFECTION 25 0.0038
461 DRY SKIN 504 0.0038
462 LUNG DISORDER 185 0.0038
463 INJECTION SITE MASS 139 0.0038
464 BLOOD POTASSIUM INCREASED 61 0.0038
465 HOSPICE CARE 37 0.0037
466 IMMUNE SYSTEM DISORDER 49 0.0037
467 PYELONEPHRITIS 32 0.0037
468 RENAL IMPAIRMENT 310 0.0037
469 OSTEOARTHRITIS 156 0.0037
470 SKELETAL INJURY 38 0.0037
471 DEHYDRATION 489 0.0037
472 DIVERTICULUM 26 0.0037
473 EAR PAIN 71 0.0036
474 OSTEOPOROSIS 150 0.0036
475 INJECTION SITE NODULE 40 0.0036
476 BLOOD DISORDER 29 0.0036
477 ORAL DISCOMFORT 50 0.0036
478 PNEUMOTHORAX 57 0.0036
479 DYSGEUSIA 267 0.0036
480 BLOOD MAGNESIUM DECREASED 31 0.0036
481 FACIAL PAIN 32 0.0036
482 CYSTITIS 114 0.0036
483 DERMATITIS ALLERGIC 45 0.0036
484 UTERINE LEIOMYOMA 26 0.0036
485 DISCOMFORT 217 0.0036
486 DEPRESSED MOOD 188 0.0036
487 PHARYNGITIS 44 0.0035
488 INFLAMMATION 183 0.0035
489 SPINAL FRACTURE 71 0.0035
490 HEPATIC ENCEPHALOPATHY 33 0.0035
491 UPPER-AIRWAY COUGH SYNDROME 29 0.0035
492 DYSPEPSIA 346 0.0035
493 SCRATCH 37 0.0035
494 BRONCHOSPASM 50 0.0035
495 ARTHRALGIA 1453 0.0035
496 RENAL PAIN 37 0.0035
497 DIABETES MELLITUS 266 0.0035
498 PULMONARY THROMBOSIS 38 0.0035
499 BRAIN NEOPLASM 32 0.0035
500 HYPERBILIRUBINAEMIA 36 0.0035
501 HEAD DISCOMFORT 61 0.0034
502 POLYURIA 28 0.0034
503 NEOPLASM MALIGNANT 228 0.0034
504 VOMITING 1605 0.0034
505 PELVIC PAIN 62 0.0034
506 ULCER 54 0.0034
507 BLOOD PRESSURE DIASTOLIC DECREASED 25 0.0034
508 ILEUS 42 0.0034
509 RETCHING 72 0.0034
510 PETECHIAE 35 0.0034
511 SMALL INTESTINAL OBSTRUCTION 41 0.0033
512 INJECTION SITE DISCOMFORT 35 0.0033
513 PAIN IN EXTREMITY 980 0.0033
514 DYSPHONIA 194 0.0033
515 DRY MOUTH 269 0.0033
516 DYSPHAGIA 313 0.0033
517 APHONIA 46 0.0033
518 ABNORMAL FAECES 27 0.0033
519 ACUTE HEPATIC FAILURE 45 0.0033
520 OEDEMA PERIPHERAL 400 0.0033
521 CHOLECYSTITIS 39 0.0033
522 SKIN REACTION 46 0.0033
523 BOWEL MOVEMENT IRREGULARITY 25 0.0033
524 BLOOD THYROID STIMULATING HORMONE INCREASED 30 0.0033
525 DYSURIA 120 0.0033
526 SKIN ULCER 84 0.0032
527 THERMAL BURN 23 0.0032
528 DEATH 2782 0.0032
529 TENDON DISORDER 21 0.0032
530 MUSCLE DISORDER 26 0.0032
531 PRODUCTIVE COUGH 153 0.0032
532 PYREXIA 1109 0.0032
533 CHILLS 375 0.0032
534 PULMONARY CONGESTION 42 0.0032
535 HYPOAESTHESIA ORAL 48 0.0032
536 TOOTH LOSS 66 0.0032
537 CONJUNCTIVITIS 59 0.0032
538 CHOLELITHIASIS 104 0.0032
539 GAIT DISTURBANCE 606 0.0032
540 HYPERAESTHESIA 26 0.0032
541 LIVER FUNCTION TEST ABNORMAL 92 0.0032
542 ILLNESS 325 0.0032
543 DRY EYE 157 0.0031
544 GAIT INABILITY 105 0.0031
545 ABDOMINAL DISCOMFORT 526 0.0031
546 BURSITIS 38 0.0031
547 BLOOD POTASSIUM DECREASED 94 0.0031
548 HEPATIC ENZYME INCREASED 213 0.0031
549 BREAST CANCER FEMALE 83 0.0031
550 DEFORMITY 29 0.0031
551 HYPOKINESIA 45 0.0031
552 PNEUMOCYSTIS JIROVECII PNEUMONIA 31 0.0031
553 HYPOAESTHESIA 462 0.0031
554 GASTROOESOPHAGEAL REFLUX DISEASE 248 0.0031
555 THIRST 55 0.0031
556 SKIN DISCOLOURATION 141 0.0031
557 OROPHARYNGEAL PAIN 284 0.0031
558 ASPHYXIA 25 0.0031
559 BONE LOSS 46 0.0031
560 HAIR COLOUR CHANGES 38 0.0031
561 SLEEP DISORDER 214 0.0030
562 NASAL DISCOMFORT 24 0.0030
563 BLOOD PRESSURE SYSTOLIC INCREASED 59 0.0030
564 BLOOD SODIUM DECREASED 57 0.0030
565 BLOOD PRESSURE ABNORMAL 60 0.0030
566 DYSSTASIA 88 0.0030
567 ELECTROLYTE IMBALANCE 35 0.0030
568 ANAL INCONTINENCE 27 0.0030
569 WHITE BLOOD CELL COUNT INCREASED 115 0.0030
570 DRUG-INDUCED LIVER INJURY 94 0.0030
571 URINARY TRACT INFECTION 509 0.0030
572 CARDIOMYOPATHY 44 0.0030
573 ABSCESS 47 0.0029
574 IRON DEFICIENCY ANAEMIA 27 0.0029
575 RASH 1274 0.0029
576 DYSPNOEA 1654 0.0029
577 CHOKING 57 0.0029
578 GASTROINTESTINAL PAIN 32 0.0029
579 PAIN 1786 0.0029
580 PERIPHERAL SWELLING 447 0.0029
581 RED BLOOD CELL SEDIMENTATION RATE INCREASED 32 0.0029
582 MUSCLE STRAIN 25 0.0029
583 FEMUR FRACTURE 89 0.0029
584 MALAISE 1257 0.0029
585 JOINT STIFFNESS 75 0.0029
586 COVID-19 498 0.0028
587 LYMPHOPENIA 40 0.0028
588 HEPATIC CYTOLYSIS 36 0.0028
589 ELECTROCARDIOGRAM ABNORMAL 22 0.0028
590 CARPAL TUNNEL SYNDROME 39 0.0028
591 THROMBOTIC MICROANGIOPATHY 27 0.0028
592 ORAL HERPES 54 0.0028
593 HEPATOCELLULAR INJURY 39 0.0027
594 RASH PRURITIC 149 0.0027
595 ISCHAEMIC STROKE 49 0.0027
596 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 47 0.0027
597 HYPOPHAGIA 70 0.0027
598 LIGAMENT SPRAIN 27 0.0027
599 OEDEMA 148 0.0027
600 GLOSSODYNIA 61 0.0027
601 HYPOTHYROIDISM 87 0.0027
602 SECRETION DISCHARGE 34 0.0027
603 UROSEPSIS 25 0.0027
604 OVARIAN CYST 27 0.0027
605 ABDOMINAL PAIN 628 0.0027
606 PERIPHERAL COLDNESS 37 0.0027
607 DECREASED ACTIVITY 29 0.0027
608 LOCALISED INFECTION 65 0.0027
609 EMPHYSEMA 27 0.0027
610 ABDOMINAL DISTENSION 279 0.0027
611 ABDOMINAL PAIN UPPER 550 0.0027
612 VAGINAL DISCHARGE 27 0.0027
613 TREATMENT FAILURE 221 0.0027
614 ARRHYTHMIA 126 0.0027
615 CONTUSION 256 0.0027
616 CHROMATURIA 60 0.0027
617 PARALYSIS 38 0.0027
618 THROMBOSIS 213 0.0026
619 NERVOUSNESS 137 0.0026
620 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 25 0.0026
621 INCREASED APPETITE 50 0.0026
622 HIP FRACTURE 83 0.0026
623 MULTIPLE ORGAN DYSFUNCTION SYNDROME 73 0.0026
624 NECK PAIN 144 0.0026
625 HYPERTENSION 544 0.0026
626 HAEMOLYTIC ANAEMIA 23 0.0026
627 SKIN EXFOLIATION 216 0.0026
628 INFECTION 369 0.0025
629 URINARY RETENTION 85 0.0025
630 POLLAKIURIA 106 0.0025
631 MYALGIA 432 0.0025
632 CATARACT 151 0.0025
633 UPPER RESPIRATORY TRACT INFECTION 116 0.0025
634 SUPRAVENTRICULAR TACHYCARDIA 24 0.0025
635 PNEUMONIA BACTERIAL 23 0.0025
636 PULMONARY FIBROSIS 48 0.0025
637 MEMORY IMPAIRMENT 343 0.0025
638 BURNING SENSATION 175 0.0025
639 RESTLESSNESS 91 0.0025
640 SKIN LACERATION 27 0.0025
641 DRUG ERUPTION 44 0.0025
642 DIZZINESS POSTURAL 24 0.0025
643 SWELLING 231 0.0025
644 ASPIRATION 27 0.0025
645 CARDIAC MURMUR 21 0.0024
646 COLITIS 92 0.0024
647 BRAIN FOG 38 0.0024
648 HEAD INJURY 76 0.0024
649 PULMONARY HYPERTENSION 50 0.0024
650 THYROID DISORDER 37 0.0024
651 ACUTE RESPIRATORY FAILURE 46 0.0024
652 PARAESTHESIA 376 0.0024
653 NIGHT SWEATS 77 0.0024
654 NOCTURIA 29 0.0024
655 DEEP VEIN THROMBOSIS 155 0.0024
656 BLOOD GLUCOSE INCREASED 449 0.0024
657 HYPERSOMNIA 68 0.0024
658 PRODUCT DISTRIBUTION ISSUE 22 0.0024
659 HYPOMAGNESAEMIA 33 0.0024
660 SCAB 27 0.0024
661 THROAT IRRITATION 106 0.0024
662 PARAESTHESIA ORAL 34 0.0024
663 MYOCARDITIS 27 0.0024
664 RESPIRATORY FAILURE 171 0.0023
665 RASH MACULO-PAPULAR 52 0.0023
666 BLISTER 131 0.0023
667 CARDIAC FAILURE 186 0.0023
668 VISUAL IMPAIRMENT 287 0.0023
669 MUSCULAR WEAKNESS 263 0.0023
670 EYE INFLAMMATION 22 0.0023
671 GLYCOSYLATED HAEMOGLOBIN INCREASED 58 0.0023
672 CHOLESTASIS 44 0.0023
673 NERVE COMPRESSION 21 0.0023
674 FLATULENCE 129 0.0023
675 FEBRILE NEUTROPENIA 150 0.0023
676 SINUS TACHYCARDIA 32 0.0023
677 BACTERIAL INFECTION 42 0.0022
678 LIMB INJURY 61 0.0022
679 HYPOXIA 79 0.0022
680 RENAL TUBULAR NECROSIS 22 0.0022
681 INFLUENZA 249 0.0022
682 HYPOACUSIS 96 0.0022
683 POOR QUALITY SLEEP 48 0.0022
684 PRURITUS 853 0.0022
685 VENTRICULAR EXTRASYSTOLES 23 0.0022
686 MYELODYSPLASTIC SYNDROME 32 0.0022
687 DIZZINESS 1103 0.0022
688 BLOOD IRON DECREASED 26 0.0022
689 CHEST PAIN 405 0.0022
690 ROTATOR CUFF SYNDROME 28 0.0022
691 CYST 27 0.0022
692 SINUS BRADYCARDIA 21 0.0022
693 FEELING HOT 133 0.0022
694 NEUROTOXICITY 38 0.0022
695 SWELLING FACE 141 0.0022
696 MUSCLE SPASMS 396 0.0022
697 OBSTRUCTIVE AIRWAYS DISORDER 24 0.0022
698 SLUGGISHNESS 22 0.0022
699 PAIN OF SKIN 58 0.0022
700 HYPERSENSITIVITY 399 0.0021
701 PANCREATITIS ACUTE 48 0.0021
702 TEMPERATURE INTOLERANCE 22 0.0021
703 TENDONITIS 33 0.0021
704 ERYTHEMA 438 0.0021
705 DIVERTICULITIS 59 0.0021
706 GASTROENTERITIS 31 0.0021
707 DISEASE RECURRENCE 101 0.0021
708 FEELING ABNORMAL 505 0.0021
709 MICTURITION URGENCY 24 0.0021
710 URINARY INCONTINENCE 62 0.0021
711 SKIN HAEMORRHAGE 31 0.0021
712 RENAL FAILURE 277 0.0021
713 RENAL DISORDER 97 0.0021
714 JOINT DISLOCATION 22 0.0021
715 DEVICE RELATED INFECTION 32 0.0021
716 NASOPHARYNGITIS 383 0.0021
717 VIRAL INFECTION 69 0.0021
718 ARTHRITIS 163 0.0021
719 SINUS DISORDER 41 0.0021
720 ACUTE KIDNEY INJURY 316 0.0021
721 MOBILITY DECREASED 148 0.0021
722 JOINT INJURY 44 0.0021
723 ATRIAL FIBRILLATION 200 0.0021
724 HERPES ZOSTER 118 0.0021
725 EAR DISCOMFORT 21 0.0020
726 COAGULOPATHY 34 0.0020
727 BLOOD TRIGLYCERIDES INCREASED 36 0.0020
728 THROAT TIGHTNESS 55 0.0020
729 COVID-19 PNEUMONIA 24 0.0020
730 INSOMNIA 540 0.0020
731 SEPSIS 226 0.0020
732 EYE DISCHARGE 21 0.0020
733 PRESYNCOPE 49 0.0020
734 BRONCHITIS 149 0.0020
735 COORDINATION ABNORMAL 28 0.0020
736 RASH MACULAR 70 0.0020
737 DEAFNESS 52 0.0020
738 THERAPY CESSATION 102 0.0020
739 SPEECH DISORDER 104 0.0020
740 PRODUCT AVAILABILITY ISSUE 45 0.0020
741 ORAL CANDIDIASIS 26 0.0020
742 BLOOD CHOLESTEROL INCREASED 92 0.0020
743 PRODUCT PRESCRIBING ERROR 47 0.0020
744 PRODUCT USE ISSUE 370 0.0020
745 ERUCTATION 38 0.0020
746 HYPOGLYCAEMIA 95 0.0020
747 GASTRIC DISORDER 67 0.0020
748 WEIGHT INCREASED 437 0.0019
749 GASTRIC ULCER 37 0.0019
750 EMOTIONAL DISORDER 60 0.0019
751 OBESITY 31 0.0019
752 RESPIRATORY DISORDER 58 0.0019
753 CHEST DISCOMFORT 198 0.0019
754 ANXIETY 549 0.0019
755 RHINORRHOEA 124 0.0019
756 BODY TEMPERATURE INCREASED 39 0.0019
757 INFLUENZA LIKE ILLNESS 157 0.0019
758 HYPONATRAEMIA 107 0.0019
759 ABDOMINAL PAIN LOWER 48 0.0019
760 ILL-DEFINED DISORDER 115 0.0019
761 DIPLOPIA 49 0.0019
762 KIDNEY INFECTION 37 0.0019
763 GLAUCOMA 36 0.0019
764 INJECTION SITE EXTRAVASATION 23 0.0019
765 GENERALISED OEDEMA 23 0.0019
766 TACHYCARDIA 165 0.0019
767 UPPER LIMB FRACTURE 37 0.0019
768 HAEMATEMESIS 47 0.0019
769 VERTIGO 113 0.0019
770 MUSCLE TIGHTNESS 30 0.0019
771 DISSEMINATED INTRAVASCULAR COAGULATION 26 0.0018
772 RHABDOMYOLYSIS 77 0.0018
773 CEREBRAL INFARCTION 45 0.0018
774 SYNCOPE 184 0.0018
775 HEADACHE 1149 0.0018
776 PNEUMONIA 593 0.0018
777 INTESTINAL OBSTRUCTION 69 0.0018
778 HEMIPARESIS 31 0.0018
779 DEMENTIA 51 0.0018
780 BLOOD PRESSURE DECREASED 121 0.0018
781 DEPRESSION 409 0.0018
782 ANOSMIA 26 0.0018
783 QUALITY OF LIFE DECREASED 24 0.0018
784 CRYING 65 0.0018
785 ECZEMA 93 0.0018
786 LOCAL SWELLING 31 0.0018
787 SINUSITIS 181 0.0018
788 NASAL CONGESTION 103 0.0018
789 POISONING 22 0.0017
790 FLUID RETENTION 89 0.0017
791 FOOT FRACTURE 33 0.0017
792 FUNGAL INFECTION 58 0.0017
793 DELIRIUM 60 0.0017
794 GASTROENTERITIS VIRAL 31 0.0017
795 HEPATIC CANCER 41 0.0017
796 FREQUENT BOWEL MOVEMENTS 46 0.0017
797 CIRCULATORY COLLAPSE 29 0.0017
798 BALANCE DISORDER 147 0.0017
799 BLOOD PRESSURE INCREASED 260 0.0017
800 LACTIC ACIDOSIS 55 0.0017
801 TYPE 2 DIABETES MELLITUS 57 0.0017
802 PALLOR 46 0.0017
803 RECTAL HAEMORRHAGE 72 0.0017
804 LUNG INFECTION 26 0.0017
805 AGRANULOCYTOSIS 31 0.0017
806 FACE OEDEMA 28 0.0017
807 MENTAL STATUS CHANGES 46 0.0017
808 HUNGER 23 0.0016
809 RESPIRATORY TRACT INFECTION 43 0.0016
810 THERAPY NON-RESPONDER 74 0.0016
811 VISION BLURRED 226 0.0016
812 INJURY 115 0.0016
813 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 85 0.0016
814 SOMNOLENCE 327 0.0016
815 INJECTION SITE PAIN 497 0.0016
816 INJECTION SITE INDURATION 21 0.0016
817 FAECES DISCOLOURED 35 0.0016
818 MOOD ALTERED 44 0.0016
819 COLON CANCER 24 0.0016
820 PRODUCT DISPENSING ERROR 35 0.0016
821 ACUTE MYELOID LEUKAEMIA 25 0.0016
822 MOOD SWINGS 51 0.0016
823 FALL 532 0.0016
824 HYPERKALAEMIA 56 0.0016
825 LIP SWELLING 53 0.0016
826 SEPTIC SHOCK 69 0.0016
827 LOWER LIMB FRACTURE 30 0.0016
828 OFF LABEL USE 1367 0.0016
829 GASTROINTESTINAL DISORDER 139 0.0016
830 RASH ERYTHEMATOUS 74 0.0015
831 EYE PRURITUS 52 0.0015
832 BASAL CELL CARCINOMA 24 0.0015
833 ARTHROPATHY 85 0.0015
834 FEAR 41 0.0015
835 HAEMORRHAGE 159 0.0015
836 INJECTION SITE HAEMATOMA 22 0.0015
837 CONFUSIONAL STATE 245 0.0015
838 GALLBLADDER DISORDER 27 0.0015
839 HYPERHIDROSIS 193 0.0015
840 MENTAL DISORDER 65 0.0015
841 PHOTOPHOBIA 28 0.0015
842 RESTLESS LEGS SYNDROME 27 0.0015
843 HEART RATE INCREASED 146 0.0015
844 PRODUCT DOSE OMISSION 95 0.0015
845 HYPERTHYROIDISM 21 0.0014
846 GOUT 26 0.0014
847 ANHEDONIA 38 0.0014
848 OXYGEN SATURATION DECREASED 81 0.0014
849 TOXICITY TO VARIOUS AGENTS 243 0.0014
850 STEVENS-JOHNSON SYNDROME 32 0.0014
851 EYE DISORDER 47 0.0014
852 RASH PAPULAR 32 0.0014
853 SNEEZING 32 0.0014
854 SLEEP APNOEA SYNDROME 27 0.0014
855 AMNESIA 92 0.0014
856 LUNG NEOPLASM MALIGNANT 58 0.0014
857 ROAD TRAFFIC ACCIDENT 59 0.0014
858 MIGRAINE 134 0.0014
859 EYE SWELLING 52 0.0014
860 ANGINA PECTORIS 40 0.0014
861 TUBULOINTERSTITIAL NEPHRITIS 26 0.0014
862 ANAPHYLACTIC REACTION 76 0.0014
863 CLOSTRIDIUM DIFFICILE INFECTION 30 0.0014
864 SYRINGE ISSUE 24 0.0014
865 LOWER RESPIRATORY TRACT INFECTION 61 0.0013
866 LEUKOCYTOSIS 24 0.0013
867 RESPIRATORY TRACT CONGESTION 21 0.0013
868 CONDITION AGGRAVATED 401 0.0013
869 BLOOD URINE PRESENT 25 0.0013
870 PROTEINURIA 25 0.0013
871 ACUTE RESPIRATORY DISTRESS SYNDROME 23 0.0013
872 SWOLLEN TONGUE 40 0.0013
873 RESPIRATORY DISTRESS 35 0.0013
874 VAGINAL HAEMORRHAGE 55 0.0013
875 MUSCULOSKELETAL STIFFNESS 111 0.0013
876 DISORIENTATION 50 0.0013
877 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 60 0.0012
878 COLD SWEAT 22 0.0012
879 URTICARIA 209 0.0012
880 PALPITATIONS 146 0.0012
881 ALTERED STATE OF CONSCIOUSNESS 27 0.0012
882 NEPHROLITHIASIS 57 0.0012
883 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 222 0.0012
884 BACK DISORDER 20 0.0012
885 COMA 58 0.0012
886 COGNITIVE DISORDER 56 0.0012
887 HAEMATOCHEZIA 66 0.0012
888 DIABETES MELLITUS INADEQUATE CONTROL 21 0.0012
889 TRANSIENT ISCHAEMIC ATTACK 40 0.0012
890 WHEEZING 70 0.0012
891 EPILEPSY 36 0.0012
892 HEART RATE DECREASED 41 0.0012
893 LETHARGY 67 0.0012
894 ANAPHYLACTIC SHOCK 30 0.0012
895 HYPOTENSION 233 0.0012
896 SKIN CANCER 25 0.0012
897 MUSCULOSKELETAL DISORDER 22 0.0012
898 PROCEDURAL PAIN 32 0.0012
899 DRUG INTERACTION 183 0.0012
900 STAPHYLOCOCCAL INFECTION 38 0.0012
901 JOINT SWELLING 139 0.0012
902 HEART RATE IRREGULAR 26 0.0011
903 HAEMOPTYSIS 32 0.0011
904 POST PROCEDURAL COMPLICATION 22 0.0011
905 AMENORRHOEA 20 0.0011
906 BLOOD PRESSURE FLUCTUATION 27 0.0011
907 RASH GENERALISED 29 0.0011
908 METABOLIC ACIDOSIS 35 0.0011
909 CEREBROVASCULAR ACCIDENT 185 0.0011
910 CARDIAC DISORDER 102 0.0011
911 TINNITUS 50 0.0011
912 INJECTION SITE SWELLING 83 0.0011
913 PRODUCT USE IN UNAPPROVED INDICATION 268 0.0011
914 TREMOR 178 0.0011
915 DYSARTHRIA 40 0.0011
916 APHASIA 32 0.0011
917 CORONARY ARTERY DISEASE 32 0.0011
918 INTENTIONAL PRODUCT MISUSE 92 0.0010
919 SHOCK 24 0.0010
920 CARDIAC FAILURE CONGESTIVE 83 0.0010
921 MENTAL IMPAIRMENT 25 0.0010
922 VISUAL ACUITY REDUCED 34 0.0010
923 ACUTE MYOCARDIAL INFARCTION 30 0.0010
924 PANIC ATTACK 37 0.0010
925 PERITONITIS 21 0.0010
926 DISABILITY 20 0.0010
927 MELAENA 22 0.0010
928 PRODUCT DOSE OMISSION ISSUE 293 0.0010
929 OCULAR HYPERAEMIA 47 0.0010
930 SKIN IRRITATION 45 0.0010
931 BLINDNESS 40 0.0010
932 ENCEPHALOPATHY 24 0.0010
933 DISTURBANCE IN ATTENTION 52 0.0010
934 LOSS OF CONSCIOUSNESS 123 0.0010
935 THERAPEUTIC RESPONSE UNEXPECTED 43 0.0010
936 DRUG INEFFECTIVE 1246 0.0009
937 INJECTION SITE BRUISING 75 0.0009
938 PNEUMONIA ASPIRATION 23 0.0009
939 FLUSHING 93 0.0009
940 INTENTIONAL DOSE OMISSION 26 0.0009
941 INJECTION SITE PRURITUS 61 0.0009
942 ACNE 68 0.0009
943 NEEDLE ISSUE 26 0.0009
944 SEIZURE 103 0.0009
945 THERAPEUTIC RESPONSE DECREASED 54 0.0009
946 CARDIAC ARREST 73 0.0009
947 HAEMATURIA 30 0.0009
948 EYE PAIN 49 0.0009
949 CEREBRAL HAEMORRHAGE 30 0.0008
950 BLOOD GLUCOSE DECREASED 40 0.0008
951 INJECTION SITE REACTION 57 0.0008
952 AGITATION 60 0.0008
953 SKIN BURNING SENSATION 58 0.0008
954 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 56 0.0008
955 THERAPY INTERRUPTED 56 0.0008
956 IRRITABILITY 47 0.0008
957 ADVERSE DRUG REACTION 70 0.0008
958 GASTROINTESTINAL HAEMORRHAGE 64 0.0008
959 EYE IRRITATION 44 0.0008
960 DEPRESSED LEVEL OF CONSCIOUSNESS 29 0.0007
961 MYOCARDIAL INFARCTION 118 0.0007
962 DRUG DOSE OMISSION 111 0.0007
963 ASTHMA 74 0.0007
964 CHRONIC KIDNEY DISEASE 48 0.0006
965 ACCIDENTAL OVERDOSE 23 0.0006
966 HALLUCINATION 47 0.0006
967 INJECTION SITE ERYTHEMA 77 0.0006
968 UNDERDOSE 45 0.0006
969 RENAL FAILURE ACUTE 26 0.0006
970 ANGER 20 0.0006
971 INCORRECT ROUTE OF DRUG ADMINISTRATION 21 0.0006
972 COLITIS ULCERATIVE 26 0.0006
973 THERAPEUTIC PRODUCT EFFECT DECREASED 26 0.0006
974 BRADYCARDIA 30 0.0006
975 INTENTIONAL PRODUCT USE ISSUE 48 0.0005
976 ADVERSE EVENT 50 0.0005
977 MEDICATION ERROR 30 0.0005
978 EMOTIONAL DISTRESS 65 0.0005
979 ANGIOEDEMA 22 0.0005
980 NO ADVERSE EVENT 85 0.0005
981 INJECTION SITE HAEMORRHAGE 36 0.0005
982 INCORRECT DOSE ADMINISTERED 100 0.0004
983 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 87 0.0004
984 SURGERY 25 0.0004
985 UNEVALUABLE EVENT 32 0.0004
986 PANCREATITIS 22 0.0004
987 AGGRESSION 20 0.0004
988 BLADDER CANCER 22 0.0004
989 HOSPITALISATION 55 0.0004
990 SUICIDAL IDEATION 28 0.0003
991 RHEUMATOID ARTHRITIS 34 0.0003
992 PRODUCT STORAGE ERROR 26 0.0003
993 PSORIASIS 27 0.0002
994 OVERDOSE 40 0.0002
995 PRODUCT QUALITY ISSUE 23 0.0002